ChemoCentryx Operating Expenses 2011-2026 | CCXI

Annual Operating Expenses ChemoCentryx

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	120 M	94.3 M	83.1 M	66 M	52.2 M	47.7 M	47.4 M	45.2 M	45 M	36 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
120 M	36 M	63.7 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.33	0.91 %	$ 8.01 B	Australia
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Aurinia Pharmaceuticals AUPH	43.9 M	$ 14.11	-3.13 %	$ 1.9 B	Canada
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
BioVie BIVI	18.1 M	$ 1.29	-3.31 %	$ 1.91 M	USA
Ascendis Pharma A/S ASND	338 M	$ 216.01	-0.94 %	$ 5 B	Danmark
BioNTech SE BNTX	512 M	$ 86.86	-1.75 %	$ 27.2 B	Germany
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	216 M	$ 19.42	0.99 %	$ 908 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Corbus Pharmaceuticals Holdings CRBP	85.3 M	$ 8.18	-3.02 %	$ 109 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
CytomX Therapeutics CTMX	98.6 M	$ 4.2	-5.83 %	$ 579 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
CollPlant Biotechnologies Ltd. CLGN	8.73 M	$ 0.73	20.26 %	$ 8.36 M	Israel
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Eton Pharmaceuticals ETON	43.6 M	$ 22.9	-3.82 %	$ 616 M	USA
Exelixis EXEL	598 M	$ 41.46	0.12 %	$ 11.3 B	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.35	-3.34 %	$ 344 M	Britain
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	53.7 M	$ 2.6	-1.14 %	$ 16.3 M	USA
Fulcrum Therapeutics FULC	84.8 M	$ 6.64	-3.63 %	$ 421 K	USA
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Genmab A/S GMAB	67.9 M	$ 25.62	-0.23 %	$ 16.4 B	Danmark
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Grifols, S.A. GRFS	1.64 B	$ 7.6	-1.24 %	$ 6.83 B	Spain
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Halozyme Therapeutics HALO	218 M	$ 61.92	-1.5 %	$ 7.42 B	USA
Bellerophon Therapeutics BLPH	22.4 M	-	-74.18 %	$ 955 K	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	52.2 M	$ 4.29	-2.94 %	$ 822 M	Canada
Incyte Corporation INCY	1.62 B	$ 90.93	0.53 %	$ 17.7 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA